A multicenter, randomized phase III study of docetaxel + cisplatin (DC) vs docetaxel + carboplatin (DCb) vs vinorelbine + cisplatin (VC) in chemotherapy-naive patients (Pts) with advanced and metastatic non-small cell lung cancer (NSCLC)

Publication | Closed Access

DOI

Citations

References

2000

Year

Chandra P. Belani, Joel Veas Rodríguez, Joachim von Pawel, A Płużańska, Vera Gorbounova, M.J. Millward, Lionel Bosquée, Y Kim, F. Gamza, J. Bérille,

Lung Cancer

MedicineMetronomic TherapyBronchial NeoplasmPhase Iii StudyCancer TreatmentRadiation OncologyOncologyCancer ChemotherapyLung CancerMolecular OncologyChemotherapy-naive PatientsRadiologyHealth Sciences